“We’re so excited to announce the expansion of Viola’s mission and reach into Canada with the help of the Avicanna team,” says Harrington, CEO of Viola. “Their commitment to research and development of cannabis in the medical and pharmaceutical industries makes them the perfect biotech partner to bring Viola’s brand to our northern neighbours, and we’re looking forward to the bright future ahead,” he says.
Viola has been operating in the U.S. for a decade and Harrington has been active in creating more opportunities for communities of colour to participate in the cannabis industry.
An arm of the company, Viola Cares, is dedicated to increasing minority representation through education, equitable offerings, expungement, incubation programs and other offerings. The company intends to expand those efforts north of the border.